[Clinical Decision Making for Treatment of Diabetic Macular Oedema with DEX Implant: a Consensus Paper].
Sign Up to like & getrecommendations! Published in 2019 at "Klinische Monatsblatter fur Augenheilkunde"
DOI: 10.1055/a-1024-4089
Abstract: BACKGROUND Currently two intravitreally applied corticosteroids (dexamethasone and fluocinolone) are licensed in Germany for treatment of diabetic macular oedema (DME). The use of DEX implant for DME in daily clinical practice has not been defined… read more here.
Keywords: dex; dex implant; treatment; consensus ... See more keywords